Mid-Afternoon Market Update: Dow Jumps Over 200 Points; Neuronetics Shares Plunge
Toward the end of trading Tuesday, the Dow traded up 0.64% to 35,059.40 while the NASDAQ rose 0.34% to 14,731.57. The S&P also rose, gaining 0.65% to 4,415.65.
48 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Wilhelmina International, Inc. (NASDAQ: WHLM) shares jumped 64.4% to $7.15 after a Form 4 filing from the company showed 10% shareholder Retail Ecommerce Ventures purchased 237,500 shares of Wilhelmina.
SVB Leerink Maintains Market Perform on Translate Bio, Raises Price Target to $38
SVB Leerink analyst Geoffrey Porges maintains Translate Bio (NASDAQ:TBIO) with a Market Perform and raises the price target from $19 to $38.
William Blair Downgrades Translate Bio to Market Perform
William Blair analyst Myles Minter downgrades Translate Bio (NASDAQ:TBIO) from Outperform to Market Perform.
Stocks That Hit 52-Week Highs On Tuesday
During Tuesday's morning trading, 101 companies set new 52-week highs.
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly’s Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 2)
Sanofi Bets Big On mRNA Push With Translate Bio Acquisition For $3.2B: Highlights
A year after paying Translate Bio Inc (NASDAQ:TBIO) a whopping $425 million to develop mRNA vaccines for infectious diseases, including COVID-19, Sanofi SA (NASDAQ:SNY)…
Sanofi Announced it Will Acquire Translate Bio for $38/Share in Cash
As part of Sanofi's (NYSE: SNY) endeavor to accelerate the application of messenger RNA (mRNA) to develop therapeutics and vaccines, the company has entered into a definitive agreement with Translate Bio (NASDAQ: TBIO), a clinical-stage mRNA therapeutics comp